Paxman Scalp Cooling

Paxman Scalp Cooling is a British medical technology company founded in 1997. It specializes in designing, manufacturing, and distributing scalp cooling systems that help prevent hair loss in cancer patients undergoing chemotherapy. The Paxman Scalp Cooling System is a clinically validated device that cools the scalp to reduce blood flow and protect hair follicles, minimizing hair loss. This system has received regulatory clearance from authorities such as the FDA and PMDA, demonstrating its safety and effectiveness. The company has expanded its product line to include several series of scalp cooling systems and launched a UK Home Healthcare business in 2014 to provide access outside of hospital settings. Paxman supplies these systems to hospitals, cancer treatment centers, and home healthcare providers, while also offering training and resources to clinicians. The company is family-led, with CEO Richard Paxman at the helm, and has been actively growing its global presence, including the acquisition of competitor Dignitana in 2025. Paxman Scalp Cooling is dedicated to improving the quality of life for cancer patients through its innovative technology.

• Employees 96
• Founded 1996
• Annual Revenue $28038000